Treatment with zilebesiran showed promising antihypertensive effects.7 Our study supports the protective effect of AGTi for CAD and ischaemic stroke, aligning with the well-established role of RAS in the cardiovascular system. The gene discussed is ASIP; the disease is coronary artery disorder.